INVESTIGATION ALERT: Berger Montague PC Investigates Baxter International Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: BAX)
INVESTIGATION ALERT: Berger Montague PC Investigates Baxter International Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: BAX) |
| [01-December-2025] |
PHILADELPHIA, Dec. 1, 2025 /PRNewswire/ -- Berger Montague advises shareholders of Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) about an investigation into Baxter's Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Baxter's marketing and sale of its Novum Large Volume Pump ("Novum LVP"). Shareholders of Baxter may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bergermontague.com or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or CLICK HERE. Berger Montague's investigation is focused on whether Baxter's Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's marketing and sale of the Novum LVP, a pump used for the controlled delivery of intravenous fluids, such as blood, medication, and nutrients. In July 2025, Baxter announced that it would "voluntarily and temporarily pause shipments and planned installations of the Novum LVP." About Berger Montague Contacts: Andrew Abramowitz, Senior Counsel
SOURCE Berger Montague | ||
Company Codes: NYSE:BAX |













